Search Results - "OTT, S. M"

Refine Results
  1. 1

    Utility of automated data in identifying femoral shaft and subtrochanteric (diaphyseal) fractures by Spangler, L., Ott, S. M., Scholes, D.

    Published in Osteoporosis international (01-09-2011)
    “…Summary In women age 45 years and older, enrolled in an integrated group practice in 2007, use of ICD9 diagnostic codes, including the “not otherwise…”
    Get full text
    Journal Article
  2. 2

    Effects of three years of low-dose thiazides on mineral metabolism in healthy elderly persons by Ott, S. M., LaCroix, A. Z., Scholes, D., Ichikawa, L. E., Wu, K.

    Published in Osteoporosis international (01-09-2008)
    “…Summary In this clinical trial of 12.5 or 25 mg/day of hydrochlorothiazide, the urine calcium showed significant decreases from placebo in men at one year, but…”
    Get full text
    Journal Article
  3. 3

    Contribution of Raloxifene and Calcium and Vitamin D3 Supplementation to the Increase of the Degree of Mineralization of Bone in Postmenopausal Women by Boivin, G., Lips, P., Ott, S. M., Harper, K. D., Sarkar, S., Pinette, K. V., Meunier, P. J.

    “…Raloxifene has been shown to increase bone mineral density and reduce the risk of vertebral fracture in postmenopausal women with osteoporosis. In this study,…”
    Get full text
    Journal Article
  4. 4

    Association between caffeine intake and bone mass among young women: potential effect modification by depot medroxyprogesterone acetate use by Wetmore, C. M., Ichikawa, L., LaCroix, A. Z., Ott, S. M., Scholes, D.

    Published in Osteoporosis international (01-04-2008)
    “…Summary This study assessed associations between habitual caffeine intake and bone mass among young women. Analyses of the entire study population revealed no…”
    Get full text
    Journal Article
  5. 5

    Low-dose hydrochlorothiazide and preservation of Bone mineral density in older adults : A Randomized, double-blind, placebo-controlled trial by LACROIX, Andrea Z, OTT, Susan M, ICHIKAWA, Laura, SCHOLES, Delia, BARLOW, William E

    Published in Annals of internal medicine (03-10-2000)
    “…Thiazide may have beneficial effects on bone mineral density and may reduce risk for hip fracture. However, the existence of a causal role remains uncertain…”
    Get full text
    Journal Article
  6. 6

    Atypical femur fracture incidence in women increases with duration of bisphosphonate exposure by Lo, J.C., Grimsrud, C.D., Ott, S.M., Chandra, M., Hui, R.L., Ettinger, B.

    Published in Osteoporosis international (01-12-2019)
    “…Summary In a northern California population of older women who were treated with oral bisphosphonate drugs, the incidence of atypical femur fracture, a rare…”
    Get full text
    Journal Article
  7. 7

    Bone mineral density in women using depot medroxyprogesterone acetate for contraception by Scholes, Delia, Lacroix, Andrea Z, Ott, Susan M, Ichikawa, Laura E, Barlow, William E

    Published in Obstetrics and gynecology (New York. 1953) (01-02-1999)
    “…Objective: To evaluate the possible effects of depot medroxyprogesterone acetate injectable contraception on bone mineral density in reproductive-age women…”
    Get full text
    Journal Article
  8. 8

    Bone Structure in Patients with Low Bone Mineral Density With or Without Vertebral Fractures by Oleksik, Anna, Ott, Susan M., Vedi, Shobna, Bravenboer, Nathalie, Compston, Juliet, Lips, Paul

    Published in Journal of bone and mineral research (01-07-2000)
    “…Vertebral fractures (VFX) are caused by low bone mass and microstructural deterioration of bone tissue. The latter is not well defined. We investigated bone…”
    Get full text
    Journal Article
  9. 9

    Bone histology at autopsy and matched bone scintigraphy findings in patients with hormone refractory prostate cancer: the effect of bisphosphonate therapy on bone scintigraphy results by Roudier, M P, Vesselle, H, True, L D, Higano, C S, Ott, S M, King, S H, Vessella, R L

    Published in Clinical & experimental metastasis (01-01-2003)
    “…Bisphosphonates (BisP) are non-metabolized compounds with high bone affinity used in bone metastasis diagnosis and treatment. Currently, BisP are used to treat…”
    Get full text
    Journal Article
  10. 10

    Sensitivity and specificity of radiographic characteristics in atypical femoral fractures by Adams, A. L., Xue, F., Chantra, J. Q., Dell, R. M., Ott, S. M., Silverman, S., Giaconi, J. C., Critchlow, C.

    Published in Osteoporosis international (2017)
    “…Summary Using the American Society for Bone and Mineral Research Task Force case definition for atypical femoral fractures, sensitivity and specificity of…”
    Get full text
    Journal Article
  11. 11

    Osteoporosis in patients with cystic fibrosis by Ott, S M, Aitken, M L

    Published in Clinics in chest medicine (01-09-1998)
    “…Decreased bone density and increased risk of fractures are seen in patients with cystic fibrosis. Suboptimal vitamin D levels, nutrition problems,…”
    Get more information
    Journal Article
  12. 12
  13. 13

    Calcitriol treatment is not effective in postmenopausal osteoporosis by Ott, S M, Chesnut, 3rd, C H

    Published in Annals of internal medicine (15-02-1989)
    “…To determine if calcitriol is an effective treatment in postmenopausal osteoporosis. Double-blind, randomized clinical trial of 2 years' duration. University…”
    Get more information
    Journal Article
  14. 14

    Effects of contraceptive use on bone biochemical markers in young women by OTT, Susan M, SCHOLES, Delia, LACROIX, Andrea Z, ICHIKAWA, Laura E, YOSHIDA, Cathleen K, BARLOW, William E

    “…The purpose of this study was to compare biochemical markers of bone resorption and formation in young women using different hormonal contraceptive methods…”
    Get full text
    Journal Article
  15. 15

    The effects of pregnancy on the musculoskeletal system by Ireland, M L, Ott, S M

    Published in Clinical orthopaedics and related research (01-03-2000)
    “…During pregnancy the female body undergoes many hormonal and anatomic changes that affect the musculoskeletal system. These changes may cause various…”
    Get more information
    Journal Article
  16. 16

    Making decisions about hormone replacement therapy: Bisphosphonates should not be recommended for women aged 50 by Ott, Susan M

    Published in BMJ (21-06-2003)
    “…The long term (greater than 10 years) use of bisphosphonates might be beneficial, but they possibly could make the bone more brittle due to the profound…”
    Get full text
    Journal Article
  17. 17

    Evaluation of vertebral volumetric vs. areal bone mineral density during growth by Ott, S.M., O'Hanlan, M., Lipkin, E.W., Newell-Morris, L.

    Published in Bone (New York, N.Y.) (01-06-1997)
    “…Bone mineral “density” (BMD) measured by dual-energy X-ray absorptiometry (DEXA) does not represent the volumetric density (grams per cubic centimeter), but…”
    Get full text
    Journal Article
  18. 18

    Bone Mineral, Histomorphometry, and Body Composition in Adults with Growth Hormone Receptor Deficiency by Bachrach, Laura K., Marcus, Robert, Ott, Susan M., Rosenbloom, Arlan L., Vasconez, Oswaldo, Martinez, Victor, Martinez, Ana Lucia, Rosenfeld, Ron G., Guevara‐Aguirre, Jaime

    Published in Journal of bone and mineral research (01-03-1998)
    “…Growth hormone (GH) and insulin‐like growth factor I (IGF‐I) deficiencies have been associated with osteopenia in both children and adults. To examine the…”
    Get full text
    Journal Article
  19. 19
  20. 20

    Skeletal status of men with early and late ankylosing spondylitis by Lee, Y S, Schlotzhauer, T, Ott, S M, van Vollenhoven, R F, Hunter, J, Shapiro, J, Marcus, R, McGuire, J L

    Published in The American journal of medicine (01-09-1997)
    “…To assess the influence of extent of disease on the skeletal status of men with ankylosing spondylitis (AS). Fourteen men with AS were studied at entry and…”
    Get more information
    Journal Article